These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8091354)

  • 1. [Calcium antagonists in the secondary prevention of myocardial infarction].
    Lièvre M; Nony P
    Therapie; 1993; 48 Spec No():677-83. PubMed ID: 8091354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review.
    Moss AJ
    Circulation; 1987 Jun; 75(6 Pt 2):V148-53. PubMed ID: 3552311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myocardial infarction beyond the 48 first hours: treatment with calcium channel antagonists].
    Delahaye F; de Gevigney G; Ovize M; Landrivon G; Rabilloud M; André-Fouët X; Delaye J
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1717-24. PubMed ID: 1304145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of calcium antagonist trials in acute myocardial infarction.
    Roberts R
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III41-7. PubMed ID: 2691141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Do calcium inhibitors have any role in secondary prevention of myocardial infarction?].
    Vacheron A; Tabone X
    Ann Cardiol Angeiol (Paris); 1992 Jun; 41(6):343-7. PubMed ID: 1359828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonists after acute myocardial infarction.
    Ferrario M; Specchia G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S75-8. PubMed ID: 2483238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists in myocardial infarction.
    Zannad F; Sadoul N
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S16-9. PubMed ID: 1706009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
    Yusuf S; Lessem J; Jha P; Lonn E
    J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of calcium channel blocking drugs after myocardial infarction.
    Moss AJ
    Eur Heart J; 1986 May; 7 Suppl A():31-4. PubMed ID: 3522237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction].
    Sárosi I; Debreceni G; Mühl D; Kónyi A; Bogár L; Tekeres M; Tóth K; Habon T; Czopf L; Zámbó K; Schmidt E
    Orv Hetil; 1997 Aug; 138(31):1939-45. PubMed ID: 9280886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part II. Clinical experience with preventive effects of calcium channel blockers in atheromatous coronary artery disease.
    Just H; Frey M
    Basic Res Cardiol; 1994; 89 Suppl 1():177-84. PubMed ID: 7945172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
    Goodman S; Hill C; Bata I; Fung A; Higginson L; Lam J; Massel D; McCans J; Nasmith J; Stanton E; Thompson C; Warnica W; Langer A
    Can J Cardiol; 1996 Nov; 12(11):1183-90. PubMed ID: 9191511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonists and myocardial infarction.
    Hansen JF
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):665-70. PubMed ID: 1888690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of calcium channel-blocking drugs after Q wave and non-Q wave myocardial infarction.
    Gibson RS
    Circulation; 1989 Dec; 80(6 Suppl):IV107-19. PubMed ID: 2574639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study.
    Goldbourt U; Behar S; Reicher-Reiss H; Zion M; Mandelzweig L; Kaplinsky E
    Arch Intern Med; 1993 Feb; 153(3):345-53. PubMed ID: 8285927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium channel antagonists and myocardial ischemia or ischemia/reperfusion].
    Lièvre M; Boissel JP
    Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():91-8. PubMed ID: 8304818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcium inhibitors and post-infarction].
    Vacheron A
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):465-7. PubMed ID: 8952740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ; Heaton PC; Cluxton RJ
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium antagonists in secondary prevention after myocardial infarction.
    Persson S
    Drugs; 1991; 42 Suppl 2():54-60. PubMed ID: 1718702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.